Cardiff Oncology, Inc.CRDFNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank71
3Y CAGR-2.1%
5Y CAGR+14.2%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-2.1%/yr
vs +25.6%/yr prior
5Y CAGR
+14.2%/yr
Recent deceleration
Acceleration
-27.8pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.9x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $37.75M | -23.5% |
| 2024 | $49.33M | +7.5% |
| 2023 | $45.90M | +13.9% |
| 2022 | $40.29M | +37.9% |
| 2021 | $29.21M | +50.2% |
| 2020 | $19.45M | +14.9% |
| 2019 | $16.92M | +4.7% |
| 2018 | $16.17M | -26.9% |
| 2017 | $22.11M | -41.8% |
| 2016 | $38.01M | - |